Results · Apr-Jun 2026 · filed 5 Aug 2026
Bharat Parenterals Q1 FY27 results
Sales fell 19% to ₹93.7 crore from ₹116 crore in Apr-Jun 2025.
Operating profit fell 38% to ₹8.5 crore, an operating margin of 9.1% (down 2.8 points from a year ago).
The net loss widened to ₹3.6 crore from ₹0.87 crore.
Against Jan-Mar 2026: sales −6%, loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 93.7 | 116.0 | −19% |
| Operating profit (EBITDA) | 8.5 | 13.8 | −38% |
| Operating margin | 9.1% | 11.9% | −2.8 pts |
| Net profit | -3.6 | -0.9 | loss widens |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Change in Directorate
- 5 Aug 2026Financial Results For The Quarter Ended On June 30, 2026
- 5 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.